Healthcare Investor Sam Isaly’s Top Stock Picks Include Pfizer

Page 1 of 2

Sam Isaly’s Orbimed Advisors is a large health care fund investing in companies at various stages from venture capital to the public markets. The fund tends to focus on pharmaceutical and medical device companies as opposed to hospitals and insurers- products, one might say, as opposed to services. This is a strong contrast to most funds’ thesis on healthcare; in fact, only two of Orbimed’s ten largest 13F holdings made our list of the most popular healthcare stocks among hedge funds and one of those- Express Scripts- is a rare services company in Isaly’s portfolio.

The nature of healthcare investments requires Orbimed to take on significant regulatory risks and make sure they are up to date on major announcements and other events which can have an enormous impact on an individual stock’s price. Of course, the fund also has to ensure that its analysts understand the regulatory environment as well as the science behind a company’s product line. Isaly himself has been covering healthcare for over 40 years, roughly half of which has come as an investment manager and half of which came as an analyst for companies such as Chase Manhattan , Merrill Lynch, and Legg Mason.

Orbimed’s grand strategy is to run a portfolio that is more or less balanced between large healthcare companies and smaller-cap companies where the investment team believes that future growth is not being reflected in the current price. When we look at its most recent portfolio, we see a fairly small number of positions worth over $100 million and then a fairly broad range of healthcare stocks. In addition, while there were some large increases or decreases many of Orbimed’s top picks remained the same and we’d assume that most of them are still close to the top of the portfolio. Read on for a brief look at the fund’s five largest holdings or see the full list of stocks it reported owning.

Ken Fisher - FISHER ASSET MANAGEMENT

Isaly and his team owned 8.9 million shares of Pfizer Inc. (NYSE:PFE), making the drug manufacturer its top stock pick. Pfizer’s trailing P/E is 20, though Wall Street analysts expect earnings to be much better this year and so the stock trades at only 11 times consensus earnings for 2013. Revenue and earnings did decline at double-digit rates in the third quarter of 2012 versus a year earlier. Pfizer was also Fisher Asset Management’s favorite stock; that fund is managed by billionaire Ken Fisher (check out Fisher’s stock picks).

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

On the Move: The 10 Fastest Growing Businesses in 2015

Fast Money: The 10 Highest Paying Fast Food Restaurants

Mixing It Up: The 14 Best Music Mashups of 2014

Rito Pls Buff: The 10 Least Played Champions in LoL Season 4

10 Covers of Popular Songs that are Better than the Originals

Must See TV: The 9 Most Anticipated Shows of 2015

The 15 Biggest Box Office Bombs of All Time

10 Things The World Can’t Stand About Americans

Picture Perfect: The 6 Smartphones with the Best Cameras

The 10 Best Countries To Work In the World

A Profitable Day At The Track: 5 Tips For Betting On Horses

Tearing You Apart: 6 Bad Habits That Ruin Relationships

Learning on the Job: The 6 Biggest Mistakes Parents Make

Shopaholics Rejoice: The 12 Biggest Malls in the World

Fright Night: 10 Horror Movies Based on True Stories

Mach Mania: The 10 Fastest Jets in the World

Military Heavyweights: The 10 Countries with the Most Tanks

All In: The 7 Richest Poker Players in the World

Abracadabra: The 10 Best Magicians in the World

The 10 Richest Asian Countries in the World in 2014

Eyes in the Sky: 10 Things You Need to Know About Drones

Rising Stars: The 6 Best Silicon Valley Startups

Military Muscle: The 5 Most Advanced Armies in South America

All that Glitters: The 7 Most Luxurious Jewelry Brands in the World

5 Things You Didn’t Know About ISIS but Should

Empowering Your Money: The 5 Best Energy Stocks to Invest In

The 11 Best Android Apps You Can’t Get on iOS

The 10 Most Important International Conflicts in 2014

Mood Enhancers: The 20 Most Uplifting Songs of all Time

Lover Beware: The 8 Countries that Cheat the Most

Breath of Fresh Air: The 25 Countries with the Best Air Quality on the Planet

Singles Beware: The 8 Worst Mistakes Made on First Dates

Healthy and Happy: The 10 Countries with Lowest Healthcare Costs

The 6 Best Company Team Building Activities to Build Workplace Camaraderie

Ships Ahoy: The 10 Busiest Shipping Ports in the World

10 Productivity Tips to Save You Time and Help You Do More With Less

Grab a Bite: The Most Popular Fast Food Restaurants in America

Friday Night Thirst: The 10 Most Popular Cocktails in the World

The 6 Greatest Unsolved Mysteries We May Never Figure Out

7 Useless Products You Never Should’ve Bought

The 5 Reasons Why You’re Single and Miserable

The 7 Most Addictive Foods in the World We Can’t Stop Eating (Even Though We Should)

5 Amazing Places You Can Swim with Dolphins

The Top 7 Most Livable Countries In The World

The 10 Most Expensive Baseball Cards Ever Pulled From A Pack

The 5 Easiest Second Languages to Learn for English Speakers

Silver Spoon: The 6 Richest Families in the World

The 20 Countries with the Largest Prison Populations in the World

The Top 10 Richest Actors in the World

The 10 Best Airline Stocks to Invest In Before They Fly Too High

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!